Literature DB >> 423000

Neurosurgical management of acromegaly. Results in 82 patients treated between 1972 and 1977.

E R Laws, D G Piepgras, R V Randall, C F Abboud.   

Abstract

A consecutive series of 82 acromegalic patients who underwent transsphenoidal surgery during a 5-year period is presented. Preoperative and postoperative values for human growth hormone (HGH) were available in 80 cases. Microadenomas were present in 18 patients with a mean preoperative HGH value of 25.2 ng/ml, diffuse adenomas in 39 patients with mean of 53.8 ng/ml, and invasive adenomas in 25 with mean of 68.0 ng/ml. There was no operative mortality. The results reflected the classification of the tumors, with apparent cures accomplished in 87.5% of previously untreated patients with microadenoma, all of whom had anterior pituitary function preserved. The percentages of apparent cures in cases of diffuse adenoma (68%) and invasive adenoma (54%) were much less satisfactory. Transsphenoidal microsurgery is capable of achieving good results, particularly in patients with microadenoma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 423000     DOI: 10.3171/jns.1979.50.4.0454

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  20 in total

1.  Role of transsphenoidal operation in the management of pituitary adenomas with suprasellar extension.

Authors:  O Bynke; J Hillman
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.

Authors:  D Giannella-Neto; B L Wajchenberg; B B Mendonça; S F Almeida; M Macchione; E M Spencer
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

3.  Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions.

Authors:  P Cappabianca; A Alfieri; A Colao; D Ferone; G Lombardi; E de Divitiis
Journal:  Skull Base Surg       Date:  1999

4.  Multimodal Navigation in Endoscopic Transsphenoidal Resection of Pituitary Tumors Using Image-Based Vascular and Cranial Nerve Segmentation: A Prospective Validation Study.

Authors:  Parviz Dolati; Daniel Eichberg; Alexandra Golby; Amir Zamani; Edward Laws
Journal:  World Neurosurg       Date:  2016-06-11       Impact factor: 2.104

5.  Acromegaly with 'normal' growth hormone levels.

Authors:  K R Feingold; T J Lorenz
Journal:  West J Med       Date:  1985-01

Review 6.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

7.  Gigantism and acromegaly: report of a case and review of the literature.

Authors:  A R George; M Deen; F Atkins
Journal:  J Natl Med Assoc       Date:  1983-11       Impact factor: 1.798

Review 8.  Recent developments in the surgical treatment of pituitary tumours.

Authors:  M Feely
Journal:  Ir J Med Sci       Date:  1980-01       Impact factor: 1.568

9.  Recent developments in the treatment of acromegaly.

Authors:  D K Lüdecke
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

10.  Hemangiopericytoma in the setting of acromegaly.

Authors:  W Jeffrey Elias; Isa M Hussaina; James B Chadduck; John A Jane; Edward R Laws; M Beatriz S Lopes
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.